Research Manitoba Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2018
NCT03567473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Research Manitoba